Welcome to visit Zhongnan Medical Journal Press Series journal website!

Home Articles Vol 37,2024 No.12 Detail

Visual analysis of research on ethical review in Chinese hospitals from the perspective of institutional ethics

Published on Dec. 30, 2024Total Views: 374 times Total Downloads: 76 times Download Mobile

Author: HUANG Zhen 1 HUANG Xun 2 ZHAO Xinyi 2 HOU Shaoling 1 ZHANG Yong 1

Affiliation: 1. Department of Scientific Research, Fuyang People's Hospital, Fuyang 236000, Anhui Province, China 2. Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China

Keywords: Hospital Ethics Committees Ethical review Institutional ethics Visualization CiteSpace

DOI: 10.12173/j.issn.1004-4337.202408286

Reference: Huang Z, Huang X, Zhao XY, Hou SL, Zhang Y. Visual analysis of research on ethical review in Chinese hospitals from the perspective of institutional ethics[J]. Journal of Mathematical Medicine, 2024, 37(12): 912-921. DOI: 10.12173/j.issn.1004-4337.202408286[Article in Chinese]

  • Abstract
  • Full-text
  • References
Abstract

Objective  To explore the current research status, research hotspots and development trends in the field of ethical review of hospitals in China under the perspective of institutional ethics.

Methods  Based on the perspective of institutional ethics, the literature related to ethical review in Chinese hospitals published in the CNKI, WanFang Data, and VIP from January 1, 2014 to October 15, 2024 was used as the dataset of this study, and CiteSpace 6.2.R6 software was used to analyze information such as year of publication, authors, research institutions, and keywords, and to draw the relevant knowledge maps.

Results  A total of 569 articles were included, and the number of research publications showed an upward trend, which has formed a highly productive group of authors, but the overall collaborative network of research authors was small, and there were geographical limitations in the distribution of research institutions. Ethics, medical ethics, informed consent, ethic, clinical research, hospitals, medical research, scientific and technological ethics, ethics archives, big data, organ transplants and etc. were the hot topics of the current research. Subjects, ethical governance, scientific and technological ethics, medicine, review efficiency, privacy protection and etc. were the topics at the forefront of research in the recent 3 years.

Conclusion  Currently, the field of hospital ethical review and research is developing rapidly in China, but there is less cross-institutional and cross-regional cooperation. In the future, communication should be strengthened, resources should be shared, and the establishment of a network of in-depth cooperative relationships in the field should be promoted.

Full-text
Please download the PDF version to read the full text: download
References

1.吉萍, 祝丹娜, 肖平, 等. 伦理协作审查与互认模式的实践[J]. 中国医学伦理学, 2024, 37(5): 550-555. [Ji P, Zhu DN, Xiao P, et al. The practice of ethical collaborative review and mutual recognition model[J]. Chinese Medical Ethics, 2024, 37(5): 550-555.] DOI: 10.12026/j.issn.1001-8565.2024.05.08.

2.陈洁茹, 安婼娜, 李明玥, 等. 临床研究伦理审查的实例研究与对策思考[J]. 中国新药与临床杂志, 2023, 42(7): 439-443. [Chen JR, An RN, Li MY, et al. Empirical study and discussion on supervision of ethical review in clinical research[J]. Chinese Journal of New Drugs and Clinical Remedies, 2023, 42(7): 439-443.] DOI: 10.14109/j.cnki.xyylc.2023.07.05.

3.年宏蕾, 蒋辉, 李继红, 等. 从医疗卫生机构视角探讨免除伦理审查的误区、挑战与对策[J]. 中国医学伦理学, 2024, 37(4): 408-414. [Nian HL, Jiang H, Li JH, et al. Exploration of the misunderstandings, challenges, and countermeasures of exemption from ethical review from the perspective of medical and health institutions[J]. Chinese Medical Ethics, 2024, 37(4): 408-414.] DOI: 10.12026/j.issn.1001-8565.2024.04.05.

4.陈桂淑, 余兴睿, 朱晓旭, 等. 器官捐献移植伦理审查信息系统开发的必要性与方案设计研究[J]. 中国医学伦理学, 2024, 37(4): 428-433. [Chen GS, Yu XR, Zhu XX, et al. Research on the necessity and program design of the development of an ethical review information system for organ donation and transplantation[J]. Chinese Medical Ethics, 2024, 37(4): 428-433.] DOI: 10.12026/j.issn.1001-8565.2024.04.08.

5.李枞, 赵明杰. 医疗机构伦理的内涵、意义及挑战 [J]. 医学与哲学, 2020, 41(7): 1-5. [Li C, Zhao MJ. The connotation,significance and challenge of medical institution ethics[J]. Medicine & Philosophy, 2020, 41(7): 1-5.] DOI: 10.12014/j.issn.1002-0772.2020.07.01.

6.鲍大旺, 赵丹娜, 王玉, 等. 机构伦理视域下安徽省某三级医院不良事件管理策略研究[J]. 医学与哲学, 2022, 43(6): 31-35. [Bao DW, Zhao DN, Wang  Y, et al. Study on medical adverse events management strategy of a Level A tertiary hospital in Anhui Province from the perspective of institutional ethics[J]. Medicine & Philosophy, 2022, 43(6): 31-35.] DOI: 10.12014/j.issn.1002-0772.2022.06.06.

7.陈欢欢, 秦刚. 机构伦理视域下医院伦理审查存在问题及优化策略[J]. 中国医院管理, 2024, 44(6): 87-89. [Chen HH, Qin G. Exploring the problems and optimization strategies of hospital ethics review from the perspective of institutional ethics[J]. Chinese Hospital Management, 2024, 44(6): 87-89.] https://d.wanfangdata.com.cn/periodical/ChlQZXJpb2RpY2FsQ0hJTmV3UzIwMjQwNzA0Eg96Z3l5Z2wyMDI0MDYwMjMaCGhuNXVoazdq.

8.赵蓉英, 许丽敏. 文献计量学发展演进与研究前沿的知识图谱探析[J]. 中国图书馆学报, 2010, 36(5): 60-68. [Xu RY, Xu LM. The knowledge map of the evolution and research frontiers of the bibliometrics[J]. Journal of Library Science in China, 2010, 36(5): 60-68.] DOI: 10.13530/j.cnki.jlis.2010.05.006.

9.陈悦, 陈超美, 刘则渊, 等. CiteSpace知识图谱的方法论功能[J]. 科学学研究, 2015, 33(2): 242-253. [Chen  Y, Chen CM, Liu ZY, et al. The methodology function of CiteSpace mapping knowledge domains[J]. Studies in Science of Science, 2015, 33(2): 242-253.] DOI: 10.3969/j.issn.1003-2053.2015.02.009.

10.周苑, 周典, 田帝, 等. 基于CiteSpace软件的国内外DRG研究可视化分析[J]. 中国医院管理, 2022, 42(10): 1-4. [Zhou Y, Zhou D, Tian D, et al. CiteSpace software based visualization analysis of DRG research at home and abroad[J]. Chinese Hospital Management, 2022, 42(10): 1-4.] https://d.wanfangdata.com.cn/periodical/ChlQZXJpb2RpY2FsQ0hJTmV3UzIwMjQwNzA0Eg96Z3l5Z2wyMDIyMTAwMDEaCHl0b2U4dzlr.

11.宗淑萍. 基于普赖斯定律和综合指数法的核心著者测评——以《中国科技期刊研究》为例[J]. 中国科技期刊研究, 2016, 27(12): 1310-1314. [Zong SP. Evaluation of core authors based on Price law and the comprehensive index method:a case study of Chinese Journal of Scientific and Technical Periodicals[J]. Chinese Journal of Scientific and Technical Periodicals, 2016, 27(12): 1310-1314.] DOI: 10.11946/cjstp.201610080819.

12.国家药监局, 国家卫生健康委. 国家药监局国家卫生健康委关于发布药物临床试验质量管理规范的公告[EB/OL]. (2020-04-23) [2024-11-01]. https://www.gov.cn/zhengce/zhengceku/2020-04/28/content_5507145.htm.

13.国家药监局, 国家卫生健康委. 国家药监局国家卫生健康委关于发布《医疗器械临床试验质量管理规范》的公告[EB/OL]. (2022-03-31) [2024-11-01]. https://www.nmpa.gov.cn/ylqx/ylqxggtg/20220331144903101.html.

14.国家卫生健康委, 国家教育部, 国家科技部, 等. 关于印发涉及人的生命科学和医学研究伦理审查办法的通知[EB/OL]. (2023-02-18) [2024-11-01]. https://www.gov.cn/zhengce/zhengceku/2023-02/28/content_5743658.htm.

15.国家科技部, 国家教育部, 国家工业和信息化部, 等. 关于印发《科技伦理审查办法(试行)》的通知[EB/OL]. (2023-09-07) [2024-11-01]. https://www.most.gov.cn/xxgk/xinxifenlei/fdzdgknr/fgzc/gfxwj/gfxwj2023/202310/t20231008_188309.html.

16.国家卫生健康委, 国家中医药局, 国家疾控局. 关于印发医疗卫生机构开展研究者发起的临床研究管理办法的通知[EB/OL]. (2024-09-18) [2024-11-01]. https://www.gov.cn/zhengce/zhengceku/202409/content_6976872.htm.

17.张桂芹, 陈庆勇, 刘鹏飞. PDCA循环法在临床试验伦理委员会建设中的应用[J]. 现代医院管理, 2024, 22(5): 9-12. [Zhang GQ, Chen QY, Liu PF, et al. Application of PDCA cycle in ethics committee construction of clinical trials[J]. Modern Hospital Management, 2024, 22(5): 9-12.] DOI: 10.3969/j.issn.1672-4232.2024.05.003.

18.吴新宇, 沈燕菊, 杨庆有, 等. 新时代中医药临床研究伦理审查工作的守正创新——无锡市中医医院伦理审查体系建设实践[J]. 中国医学伦理学, 2023, 36(10): 1138-1142. [Wu XY, Shen YJ, Yang QY, et al. Integrity and innovation of ethical review in clinical research of traditional Chinese medicine in the new era: practice on the construction of ethical review system in Wuxi Traditional Chinese Medicine Hospital[J]. Chinese Medical Ethics, 2023, 36(10): 1138-1142.] https://d.wanfangdata.com.cn/periodical/Ch9QZXJpb2RpY2FsQ0hJTmV3UzIwMjQxMTA1MTcxMzA0EiNxa19mN2JhOWVkODBiZDU0NjRmYTQ3M2MzMDMwN2ZjNDMzOBoIbml4YTd6aXM%3D.

19.何斌, 李佳潞, 赵庆辉, 等. 医疗机构干细胞临床研究学术委员会建设现状与对策[J]. 中国研究型医院, 2023, 10(5): 25-30. [He B, Li JL, Zhao QH, et al. Current status and strategy for the establishment of stem cell clinical research academic committees in medical institutions[J]. Chinese Research Hospitals, 2023, 10(5): 25-30.] DOI: 10.19450/j.cnki.jcrh.2023.05.003.

20.张秋菊, 蒋辉. 医疗人工智能应用的伦理设计与原则[J]. 医学与哲学, 2021, 42(4): 22-26, 31. [Zhang  QJ, Jiang H. Ethical design and principle of medical artificial intelligence application[J]. Medicine & Philosophy, 2021, 42(4): 22-26, 31.] DOI: 10.12014/j.issn.1002-0772.2021. 04.06.

21.李鸿浩, 段伟文, 陈蕾, 等. 医疗人工智能技术研发与应用的伦理挑战和对策——以我国大型公立医院为例的思考[J]. 人工智能, 2019, (4): 70-78. [Li HH, Duan WW, Chen L, et al. Ethical challenges and countermeasures in the research and application of medical artificial intelligence technology: reflections on large public hospitals in China[J]. Artificial Intelligence View, 2019, (4): 70-78.] DOI: 10.16453/j.cnki.issn2096-5036. 2019.04.008.

22.郭芙蓉, 吴源泉, 吴建华. 基层医院伦理建设及医务人员伦理认知现状分析[J]. 中国卫生标准管理, 2023, 14(17): 58-64. [Guo FR, Wu YQ, Wu JH, et al. Analysis on the current situation of primary hospital ethics construction and medical workers' ethics cognition in remote region[J]. China Health Standard Management, 2023, 14(17): 58-64.] DOI: 10.3969/j.issn.1674-9316.2023.17.014.

23.樊景辉, 张文洁, 苏健芬, 等. 基层医院伦理委员会建设存在问题及对策[J]. 医学与哲学, 2020, 41(6): 29-31. [Fan JH, Zhang WJ, Su JF, et al. Problems and countermeasures in the construction of ethics committee in grass-roots hospitals[J]. Medicine & Philosophy, 2020, 41(6): 29-31.] DOI: 10.12014/j.issn.1002-0772.2020. 06.08.

24.耿雯倩, 秦丹, 戴明君, 等. 高风险医疗技术伦理审查和监管的问题与对策管窥——以基因编辑技术为例[J]. 中国医学伦理学, 2020, 33(6): 695-698. [Geng WQ, Qin D, Dai MJ, et al. Problems and countermeasures of ethical review and supervision of high-risk medical technologies: take gene editing technology as an example[J]. Chinese Medical Ethics, 2020, 33(6): 695-698.] DOI: 10.12026/j.issn.1001-8565.2020.06.10.

25.王雪芹, 孟丽君. 涉及脑机接口临床研究的多学科伦理审查专家共识[J]. 中国医学伦理学, 2024, 37(9): 1119-1125. [Wang XQ, Meng LJ. Expert consensus on multidisciplinary ethical review of clinical research involving brain-computer interfaces[J]. Chinese Medical Ethics, 2024, 37(9): 1119-1125.] DOI: 10.12026/j.issn.1001-8565.2024.09.15.

26.徐灵灵, 王昊, 林琳, 等. 某三甲医院科研大数据平台的临床研究管理要点探析[J]. 中国医学伦理学, 2023, 36(7): 749-753. [Xu LL, Wang H, Lin L, et al. Analysis on the key points of clinical research management based on the scientific research big data platform of a tertiary hospital[J]. Chinese Medical Ethics, 2023, 36(7): 749-753.] DOI: 10.12026/j.issn.1001-8565.2023.07.08.

27.周吉银, 刘丹. 《涉及人的生命科学和医学研究伦理审查办法》的解读和思考[J]. 中国医学伦理学, 2023, 36(5): 475-481. [Zhou JY, Liu D. Interpretation and reflection on measures for ethical review of life science and medical research involving humans[J]. Chinese Medical Ethics, 2023, 36(5): 475-481.] DOI: 10.12026/j.issn.1001-8565.2023.05.01.

28.王雨萌, 周铭, 阎昭. 中国肿瘤临床试验伦理审查互认机制调研与分析[J]. 中国癌症防治杂志, 2024, 16(2): 152-157. [Wang YM, Zhou M, Yan Z. Survey and analysis of mutual recognition mechanism for ethical review of clinical trials of tumors in China[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(2): 152-157.] DOI: 10.3969/j.issn.1674-5671.2024.02.03.

Popular papers
Last 6 months